Content Reproduced verbatim from the Website of FindLaw, A Thomson Reuters Business, as permitted under their RSS FEEDS, Terms of Use.

Merck Sharp and Dohme Corp. v. Hospira, Inc., 17-1115

Affirming the district court’s determination that patents relating to aspects of the production of an antibiotic compound were obvious implementations of disclosures made in other patents that would constitute nothing more than the routine way a skilled artisan would apply the patent’s teachings.

Appellate Information

  • Argued
  • Submitted
  • Decided
  • Published 2017/10/26



  • United States Federal Circuit


Twitter Auto Publish Powered By :